Australia markets close in 3 hours 18 minutes
  • ALL ORDS

    7,079.40
    +36.70 (+0.52%)
     
  • ASX 200

    6,821.70
    +32.10 (+0.47%)
     
  • AUD/USD

    0.7752
    -0.0025 (-0.32%)
     
  • OIL

    59.94
    -0.70 (-1.15%)
     
  • GOLD

    1,715.60
    -7.40 (-0.43%)
     
  • BTC-AUD

    63,299.00
    +2,871.51 (+4.75%)
     
  • CMC Crypto 200

    983.76
    +55.53 (+5.98%)
     
  • AUD/EUR

    0.6440
    -0.0010 (-0.15%)
     
  • AUD/NZD

    1.0684
    -0.0006 (-0.06%)
     
  • NZX 50

    12,393.13
    +91.32 (+0.74%)
     
  • NASDAQ

    13,282.95
    +373.51 (+2.89%)
     
  • FTSE

    6,588.53
    +105.10 (+1.62%)
     
  • Dow Jones

    31,535.51
    +603.14 (+1.95%)
     
  • DAX

    14,012.82
    +226.53 (+1.64%)
     
  • Hang Seng

    29,708.39
    +255.82 (+0.87%)
     
  • NIKKEI 225

    29,766.75
    +103.25 (+0.35%)
     

2020 Insights on the Global Respiratory Care Market to 2024 - Including Noninvasive Ventilation and Airway Management Products - ResearchAndMarkets.com

·3-min read

The "Respiratory Care: Noninvasive Ventilation and Airway Management Products" report has been added to ResearchAndMarkets.com's offering.

This report covers the global market including the US, five major European markets (France, Germany, Italy, Spain, and the UK) for 2019-24.

In 2019, combined global sales of the PAP-based NIV products and airway management accessories covered by this report totalled nearly $7bn, with NIV products accounting for more than two-thirds of total sales. Sales are expected to increase at a CAGR of 7.6%, reaching nearly $10bn in 2024. COVID-19 is expected to cause a surge in sales of these products in 2020-21 as less invasive ventilation devices gain popularity in treating patients in respiratory distress, and as demand for airway management accessories such as HMEs, humidifiers, and nebulizers rises with the increase in ventilated patients.

Asthma and COPD, the two most prevalent respiratory diseases, affect nearly 600 million people worldwide, with annual mortality rates exceeding 3 million for COPD and 400,000 for asthma. COVID-19 has infected more than 60 million people worldwide, resulting in 1.5 million deaths. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the positive airway pressure (PAP)-based noninvasive ventilation (NIV) and airway management products market, including CPAP and BiPAP devices as well as heat/moisture exchangers (HMEs), humidifiers, and nebulizers (including large- and small-volume nebulizers and nebulizer compressors).

Key Topics Covered:

1. Respiratory Disease Overview

1.1 Asthma

1.1.1 Etiology

1.1.2 Epidemiology

1.2 Chronic obstructive pulmonary disease

1.2.1 Etiology

1.2.2 Epidemiology

1.3 Coronavirus disease 2019

1.3.1 Etiology

1.3.2 Epidemiology

1.4 Bibliography

2. Positive Pressure-Based Noninvasive Ventilation Products

2.1 Products and technology

2.1.1 Philips Healthcare/Koninklijke Philips

2.1.2 ResMed

2.1.3 Fisher & Paykel Healthcare

2.1.4 Other suppliers

2.2 Market analysis

2.3 Competitive analysis

2.3.1 Philips Healthcare/Koninklijke Philips

2.3.2 ResMed

2.3.3 Fisher & Paykel Healthcare

2.3.4 Other competitors

2.4 Emerging technologies

2.4.1 Respicardia: remede system

2.4.2 LivaNova: THN Sleep Therapy system

2.4.3 Beyond Air: LungFit system

2.4.4 KeepMed and Merieux Equity Partners: keePAP system

2.5 Bibliography

3. Airway Management Accessories

3.1 Heat and moisture exchangers

3.1.1 Products and technology

3.1.2 Market analysis

3.1.3 Competitive analysis

3.2 Humidifiers

3.2.1 Products and technology

3.2.2 Market analysis

3.2.3 Competitive analysis

3.3 Nebulizers

3.3.1 Large-volume nebulizers

3.3.2 Small-volume nebulizers

3.3.3 Nebulizer compressors

3.3.4 Market analysis

3.3.5 Competitive analysis

3.4 Emerging technologies

3.5 Combined market analysis

3.6 Bibliography

4. Appendix: Company Listing

For more information about this report visit https://www.researchandmarkets.com/r/xvylgd

View source version on businesswire.com: https://www.businesswire.com/news/home/20210126005847/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900